We Are Accepting New Patients
Helena's only Fellowship-Trained Mohs Surgeon
Keep scrolling to learn more about available non-surgical skin cancer treatment options (other than Mohs surgery), or click on a treatment name below to jump directly to that section.
“The most efficacious, safest, and reliable treatment should be chosen for our patients over any financial consideration to the dermatologist. Radiation therapy has historically been an important therapeutic arrow in our quiver. Nonetheless, currently this is not the recommended first-line therapy for a majority of our patients.” — Grant-Kels JM, VanBeek MJ. The ethical implications of "more than one way to skin a cat": increasing use of radiation therapy to treat nonmelanoma skin cancers by dermatologists. J Am Acad Dermatol. 2014 May;70(5):945-7.
There are several types of radiation therapy used to treat various skin conditions, including skin cancers. When used by a board-certified Radiation Oncologist, typically in a hospital setting, radiation therapy can be an incredibly beneficial initial or additional therapy to treat skin cancer. Dr. Skelley, as part of his training, is particularly experienced on when to consult with his radiation oncology colleagues regarding the safe and beneficial use of radiation therapy in treating complex skin cancers. However, the use of “newer” office-based superficial radiation treatments, by non-trained providers, is not indicated as the first-line method to treat most skin cancers.
Radiation therapy involves the use of highly energetic particles directed at cancerous cells that are vulnerable to this energy. The cancer cells preferentially die after this exposure, and the normal healthy tissues survive. When used in the correct setting, radiation treatment, particularly superficial radiation therapy, can treat skin cancers, however, it also can come with many disadvantages and possible side effects.
For these various reasons, most reputable national organizations DO NOT recommend radiation treatment as the first line treatment for the majority of skin cancers. You will not find superficial radiation listed as a first-line treatment option for most patients’ skin cancers in the current dermatologic treatment guidelines (American Academy of Dermatology and the National Comprehensive Cancer Network).
Aldara (Imiquimod) is a topically applied cream that harnesses the natural function of your immune system to attack and kill cancer cells. This type of topical therapy is a beneficial treatment option for certain types of thin skin cancer. It is applied directly on the cancerous lesion, which activates the immune system to help destroy the cancer. Typically, there is a local inflammatory reaction in the skin around the site of application. This is an expected and, in fact, a good sign that the cream is having the desired effect. Rarely, however, patients can develop a tremendous reaction to the cream, and this should be reported to your provider.
Some types of skin cancer and precancerous skin lesions may be treated successfully with energy-based devices such as an electrosurgical unit or certain types of lasers. The size, shape, location, and extent of your skin cancer needs to be assessed carefully to determine if treatment by energy-based devices will be a promising option for you.
Topical chemotherapy is a form of skin cancer therapy that involves the application of a medicated cream directly on the skin cancer lesion. The active ingredient in the cream (5-flourouracil) works to gradually destroy the abnormal cells on and near the surface of the skin. This treatment is ideal for treating actinic keratoses (precancerous lesions) and superficial, early-stage skin cancers.
There are many benefits to topical chemotherapy, such as its non-invasive delivery method and minimal risk of scarring, its convenience that enables at-home treatment and the continuation of daily activities, and its side effects that are usually limited only to the treated area, instead of the whole body. However, topical chemotherapy is not ideal for treating all types of skin cancer, especially the recurrent or aggressive types of skin cancer. Common, temporary, side effects of chemotherapy cream can include mild to severe skin irritation.
Intralesional chemotherapy injections may be recommended for certain patients who have aggressive skin cancers or for patients who are not good candidates for other interventions, such as surgery. In the appropriate setting, these treatments can be a highly safe and effective option for patients. The treatment consists of a quick injection into the skin cancer, typically once a week for a few weeks depending on the size and nature of the skin cancer being treated. The skin cancer will slowly fade away with some level or local irritation at the site. After treatment, the site usually heals quite well. The treatment area is closely observed for some time to assess for any cancer recurrence.
Rarely, skin cancers can become locally advanced, or spread to other areas in the body (metastasize). When this occurs, a local destructive modality or surgical removal alone is not enough to treat the cancer. In these scenarios, a systemic, or whole body, medication may be needed. These treatments can be very beneficial when used alone or in combination with other treatments. If required, these medications are often prescribed by, or in conjunction with, our Oncology and Hematology colleagues. We work closely with these specialists to provide each patient the best possible multidisciplinary care available.
Ready to schedule an appointment at Guardian Dermatology? Please call us at 406-272-5941 or click on the button below to get in touch.
Guardian Dermatology, P.C. | All Rights Reserved